Cancer Family
Basal Cell Neoplasm
CI-CAN-00000072Explore in graph →
Non-malignant58 active trials4 approved drugs6 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000072Explore in graph →
Clinical trials
362 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07455331 | Flash Radiotherapy for Skin Cancer(LANCE) | not yet recruiting | Phase 2 | 60 | Jules Bordet InstituteOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT00959647 | A Study of Vismodegib (GDC-0449) in Patients Treated With Vismodegib in a Previous Genentech-sponsored Phase I or II Cancer Study | completed | Phase 2 | 19 | Genentech, Inc.INDUSTRY | 1 | May 8, 2026 | clinicaltrials |
| NCT06384924 |
| Raman Spectroscopy and Skin Cancer |
| recruiting |
| — |
| 20 |
| Tiezhi ZhangOTHER |
| 1 |
| May 7, 2026 |
| clinicaltrials |
| NCT07358637 | AI-enhanced OCT Imaging for Pre-surgical Margin Detection of Basal Cell Carcinoma | not yet recruiting | — | 30 | Henry Ford Health SystemOTHER | 0 | May 6, 2026 | clinicaltrials |
| NCT07571031 | Inter-Operator Variability in the Clinical Staging and Therapeutic Management of Basal Cell Carcinoma(BASIX) | not yet recruiting | — | 20 | Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER | 0 | May 6, 2026 | clinicaltrials |
| NCT06608238 | Phase 2 Study Evaluating the Safety and Efficacy of Microneedle-mediated Delivery of Doxorubicin (D-MNA) in Patients With Nodular Basal Cell Carcinoma. | completed | Phase 2 | 90 | SkinJect, Inc.INDUSTRY | 2 | May 4, 2026 | clinicaltrials |
| NCT03521830 | Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma | recruiting | Phase 2 | 57 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Apr 29, 2026 | clinicaltrials |
| NCT06483555 | Basal-like PDAC Treated With Gemcitabine, Erlotinib, and Nab-paclitaxel(PANGEA) | recruiting | Phase 1 / Phase 2 | 104 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 23, 2026 | clinicaltrials |
| NCT02667574 | Study Evaluating the Interest of Vismodegib as Neo-adjuvant Treatment of Basal Cell Carcinoma (BCC)(VISMONEO) | completed | Phase 2 | 55 | University Hospital, LilleOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT04349436 | Study to Investigate the Efficacy and Safety of RP1 in Adult Patients With Organ Transplants and Advanced Skin Malignancies(ARTACUS) | active not recruiting | Phase 1 / Phase 2 | 69 | Replimune, Inc.INDUSTRY | 1 | Apr 22, 2026 | clinicaltrials |
| NCT05294120 | A Study on Radiation Therapy Guided by the Reflectance Confocal Microscopy (RCM)/Optical Coherence Tomography (OCT) Device in People With Basal Cell Carcinoma | active not recruiting | Phase 2 | 38 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT05969860 | At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer | recruiting | Phase 2 | 220 | Mayo ClinicOTHER | 1 | Apr 20, 2026 | clinicaltrials |
| NCT03646188 | Dose Escalation Trial to Evaluate Dose Limiting Toxicity/Maximum Tolerated Dose of Microneedle Arrays Containing Doxorubicin (D-MNA) in Basal Cell Carcinoma (BCC) | terminated | Phase 1 | 13 | SkinJect, Inc.INDUSTRY | 1 | Apr 16, 2026 | clinicaltrials |
| NCT05814900 | Investigation of Mohs Surgical Margins Using Two Photon Microscopy | completed | N/A | 135 | University of RochesterOTHER | 1 | Apr 2, 2026 | clinicaltrials |
| NCT05651828 | Adaptive Therapy of Vismodegib in Advanced Basal Cell Carcinoma | recruiting | Early Phase 1 | 34 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 1 | Apr 1, 2026 | clinicaltrials |
| NCT07501780 | Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice(RELI) | not yet recruiting | — | 297 | Maastricht University Medical CenterOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT05724875 | FLASH Radiotherapy for Skin Cancer(LANCE) | active not recruiting | N/A | 60 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT04480645 | CivaDerm(TM) Surface Therapy Pilot Study | completed | Early Phase 1 | 10 | CivaTech OncologyINDUSTRY | 1 | Mar 24, 2026 | clinicaltrials |
| NCT04744935 | Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma | active not recruiting | N/A | 40 | Christopher ZacharyOTHER | 1 | Mar 24, 2026 | clinicaltrials |
| NCT07482956 | BCC-One-Stop-Study | not yet recruiting | N/A | 290 | University Hospital AugsburgOTHER | 1 | Mar 19, 2026 | clinicaltrials |
| NCT04066504 | Post-authorization Safety Study on the Long Term Safety of Sonidegib in Patients With Locally Advanced Cell Carcinoma(NISSO) | completed | — | 323 | Sun Pharmaceutical Industries LimitedINDUSTRY | 4 | Mar 18, 2026 | clinicaltrials |
| NCT06981325 | Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients(CEMI-first) | recruiting | Phase 2 | 34 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus NordwestOTHER | 1 | Mar 11, 2026 | clinicaltrials |
| NCT07428941 | Evaluating an Artificial Intelligence Tool to Help Primary Care Doctors Diagnose Skin Conditions.(LegitHealth PH) | completed | — | 9 | AI Labs Group S.LINDUSTRY | 1 | Feb 24, 2026 | clinicaltrials |
| NCT07384078 | High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults(HIFUvsCRYO) | not yet recruiting | N/A | 294 | Jussi SalonenOTHER | 1 | Feb 3, 2026 | clinicaltrials |
| NCT07381972 | Photodynamic Therapy Associated With Sonodynamic Therapy for the Treatment of Nodular Basal Cell Carcinoma | recruiting | Phase 3 | 142 | University of Sao PauloOTHER | 1 | Feb 2, 2026 | clinicaltrials |
| NCT06623201 | Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas | recruiting | Phase 1 | 20 | Nathalie ZeitouniOTHER | 1 | Jan 29, 2026 | clinicaltrials |
| NCT07361666 | Impact of Preoperative High-Frequency Ultrasound Cutaneous Lesion Extent Assessment on Excision Margin Positivity in Head and Neck Skin Cancer, and the Relationship Between Preoperative Assessment Methods, Inadequate Excision Margins, and Tumor Recurrence(HFUS-CLEAR) | not yet recruiting | — | 400 | Państwowy Instytut Medyczny Ministerstwa Spraw Wewnętrznych i AdministracjiOTHER_GOV | 1 | Jan 23, 2026 | clinicaltrials |
| NCT03889912 | Intralesional Cemiplimab for Adult Patients With Cutaneous Squamous Cell Carcinoma or Basal Cell Carcinoma | completed | Phase 1 | 97 | Regeneron PharmaceuticalsINDUSTRY | 3 | Jan 21, 2026 | clinicaltrials |
| NCT07347392 | The Role of Radiotherapy for the Management of Non-melanoma Skin Cancer in Denmark.(DOSCA-2) | enrolling by invitation | — | 2,900 | University of AarhusOTHER | 1 | Jan 16, 2026 | clinicaltrials |
| NCT03573401 | Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). | active not recruiting | Phase 3 | 187 | Biofrontera Inc.INDUSTRY | 1 | Jan 14, 2026 | clinicaltrials |
| NCT07311070 | Treatment of Basal Cell Carcinoma (BCC) of the Skin, of the Morpheiform, Infiltrative, and Noduloulcerative Types in Inoperable Patients and Not Suitable for Radiotherapy Using Formulated Methylene Blue | enrolling by invitation | Phase 3 | 20 | Daryoush Hamidi Alamdari, PhDOTHER | 1 | Jan 6, 2026 | clinicaltrials |
| NCT03509467 | Using MC1R Genotype to Impact Melanoma Risk Behavior | completed | N/A | 2,054 | H. Lee Moffitt Cancer Center and Research InstituteOTHER | 2 | Dec 19, 2025 | clinicaltrials |
| NCT03534947 | A Study to Evaluate Neoadjuvant Sonidegib Followed by Surgery or Imiquimod in the Management of Basal Cell Carcinoma(SONIB) | completed | Phase 2 | 16 | Melanoma Institute AustraliaOTHER | 1 | Dec 16, 2025 | clinicaltrials |
| NCT07251413 | Cemiplimab Plus Imiquimod and Laser Therapy As Neoadjuvant Treatment In Cutaneous Basal Cell Carcinoma(CEMIQUID) | recruiting | Phase 1 / Phase 2 | 18 | Instituto Oncológico Dr RosellOTHER | 1 | Dec 1, 2025 | clinicaltrials |
| NCT05381597 | 5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer | recruiting | Phase 2 / Phase 3 | 200 | Boston UniversityOTHER | 1 | Nov 28, 2025 | clinicaltrials |
| NCT01455363 | Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma(HPOB) | completed | N/A | 12 | Institut CurieOTHER | 1 | Nov 24, 2025 | clinicaltrials |
| NCT06132191 | Expanded Access Use of Cemiplimab in Patients With Solid Tumors | approved for marketing | — | — | Regeneron PharmaceuticalsINDUSTRY | 0 | Nov 20, 2025 | clinicaltrials |
| NCT04272034 | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors | terminated | Phase 1 | 105 | Incyte CorporationINDUSTRY | 7 | Oct 16, 2025 | clinicaltrials |
| NCT03836105 | CemiplimAb Survivorship Epidemiology(CASE) | completed | — | 287 | Regeneron PharmaceuticalsINDUSTRY | 2 | Oct 15, 2025 | clinicaltrials |
| NCT05133427 | HIFU for Treatment of Non-nodular and Recurrent BCC(BCC-HIFU2101) | active not recruiting | N/A | 40 | Joergen SerupOTHER | 1 | Oct 3, 2025 | clinicaltrials |
| NCT05561634 | Radiotherapy by Sonic Hedgehog Pathway Inhibitors in Basal Cell Carcinoma(RADIOSONIC) | recruiting | Phase 2 | 82 | University Hospital, LilleOTHER | 1 | Sep 30, 2025 | clinicaltrials |
| NCT06813833 | Transcriptomic Analysis and Optical Coherence Tomography Combined for Patients With Basal Cell Carcinoma(RNA-OCT-BCC) | completed | — | 50 | Bispebjerg HospitalOTHER | 1 | Sep 19, 2025 | clinicaltrials |
| NCT06536257 | Personalised Immunotherapy Platform(PIP-PREDICT) | recruiting | — | 1,000 | Melanoma Institute AustraliaOTHER | 1 | Sep 18, 2025 | clinicaltrials |
| NCT07010692 | Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment | recruiting | Phase 1 / Phase 2 | 100 | Bruce Robinson, MDOTHER | 1 | Sep 17, 2025 | clinicaltrials |
| NCT06683846 | Ivonescimab in the Treatment of Multiple Advanced Tumors | recruiting | Phase 2 | 400 | Fudan UniversityOTHER | 1 | Aug 24, 2025 | clinicaltrials |
| NCT07068568 | Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma(BCC-Sonidegib) | completed | — | 12 | Federico II UniversityOTHER | 1 | Jul 16, 2025 | clinicaltrials |
| NCT05086692 | A Beta-only IL-2 ImmunoTherapY Study(ABILITY-1) | recruiting | Phase 1 / Phase 2 | 115 | Medicenna Therapeutics, Inc.INDUSTRY | 7 | Jul 9, 2025 | clinicaltrials |
| NCT06654999 | How Consistent is the Output of DERM, When Used to Assess Images of Potentially Cancerous Skin Lesions. | completed | — | 115 | Skin Analytics LimitedINDUSTRY | 1 | Jul 9, 2025 | clinicaltrials |
| NCT05188729 | Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma | completed | Phase 2 | 92 | Verrica Pharmaceuticals Inc.INDUSTRY | 1 | Jun 18, 2025 | clinicaltrials |
| NCT05138328 | Laser Treatment of Basal Cell Carcinoma Under Imaging Guidance | completed | N/A | 31 | Henry Ford Health SystemOTHER | 1 | Jun 15, 2025 | clinicaltrials |
Data updated 22 days agoSource updated May 11, 2026source: clinicaltrials